{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HPLC-PDA/MS", "in vitro stability", "metabolomics", "parasitic infections", "stability", "triterpenes"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34885738", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "26"}], "Language": ["eng"], "ELocationID": ["7154", "10.3390/molecules26237154"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "23", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "26"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "A Validated HPLC-PDA-HRMS Method to Investigate the Biological Stability and Metabolism of Antiparasitic Triterpenic Esters.", "Abstract": {"AbstractText": ["Pentacyclic triterpenes (PTs) are commonly found in medicinal plants with well-known antiparasitic effects. Previous research on C-3 and C-27 triterpenic esters showed effective and selective in vitro antiparasitic activities and in vivo effectiveness by parenteral routes. The aim of this study was to determine triterpenic esters' stability in different biological-like media and the main microsomal degradation products. An HPLC-PDA method was developed and validated to simultaneously analyze and quantify bioactive triterpenic esters in methanol (LOQ: 2.5 and 1.25-100 \u00b5g/mL) and plasma (LOQ: 5-125 \u00b5g/mL). Overall, both triterpenic esters showed a stable profile in aqueous and buffered solutions as well as in entire plasma, suggesting gaining access to the ester function is difficult for plasma enzymes. Conversely, after 1 h, 30% esters degradation in acidic media was observed with potential different hydrolysis mechanisms. C-3 (15 and 150 \u00b5M) and C-27 esters (150 \u00b5M) showed a relatively low hepatic microsomal metabolism (<23%) after 1 h, which was significantly higher in the lowest concentration of C-27 esters (15 \u00b5M) (>40% degradation). Metabolic HPLC-PDA-HRMS studies suggested hydrolysis, hydroxylation, dehydration, <i>O</i>-methylation, hydroxylation and/or the reduction of hydrolyzed derivatives, depending on the concentration and the position of the ester link. Further permeability and absorption studies are required to better define triterpenic esters pharmacokinetic and specific formulations designed to increase their oral bioavailability."]}, "AuthorList": [{"Identifier": ["0000-0002-2512-5921"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Laboratory, Louvain Drug Research Institute (LDRI), Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue E. Mounier, B1 72.03, B-1200 Brussels, Belgium."}], "LastName": "Schioppa", "ForeName": "Laura", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Laboratory, Louvain Drug Research Institute (LDRI), Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue E. Mounier, B1 72.03, B-1200 Brussels, Belgium."}], "LastName": "Fall", "ForeName": "Fanta", "Initials": "F"}, {"Identifier": ["0000-0002-1596-4887"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Laboratory, Louvain Drug Research Institute (LDRI), Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue E. Mounier, B1 72.03, B-1200 Brussels, Belgium."}], "LastName": "Ortiz", "ForeName": "Sergio", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Research Group (CMFA), Louvain Drug Research Institute (LDRI), Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue E. Mounier, B1 72.04, B-1200 Brussels, Belgium."}], "LastName": "Poupaert", "ForeName": "Jacques H", "Initials": "JH"}, {"Identifier": ["0000-0002-2278-6206"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Laboratory, Louvain Drug Research Institute (LDRI), Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue E. Mounier, B1 72.03, B-1200 Brussels, Belgium."}], "LastName": "Quetin-Leclercq", "ForeName": "Joelle", "Initials": "J"}], "GrantList": [{"GrantID": "T.0092.20", "Agency": "Fund for Scientific Research", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiparasitic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Esters"}, {"RegistryNumber": "0", "NameOfSubstance": "Pentacyclic Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiparasitic Agents"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Esters"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hydrolysis"}, {"QualifierName": ["chemistry", "isolation & purification"], "DescriptorName": "Pentacyclic Triterpenes"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry", "parasitology"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Control of Neglected Tropical Diseases.  [(accessed on 10 February 2021)].  Available online:  https://www.who.int/teams/control-of-neglected-tropical-diseases."}, {"Citation": "B\u00fcscher P., Cecchi G., Jamonneau V., Priotto G. Human African trypanosomiasis. Lancet. 2017;390:2397\u20132409. doi: 10.1016/S0140-6736(17)31510-6.", "ArticleIdList": ["10.1016/S0140-6736(17)31510-6", "28673422"]}, {"Citation": "Prevention C.-C. For D.C. and CDC\u2014Malaria\u2014Malaria Worldwide\u2014Impact of Malaria.  [(accessed on 20 October 2021)];2021  Available online:  https://www.cdc.gov/malaria/malaria_worldwide/impact.html."}, {"Citation": "Conteh L., Engels T., Molyneux D.H. Socioeconomic aspects of neglected tropical diseases. Lancet. 2010;375:239\u2013247. doi: 10.1016/S0140-6736(09)61422-7.", "ArticleIdList": ["10.1016/S0140-6736(09)61422-7", "20109925"]}, {"Citation": "Ashley E.A., Dhorda M., Fairhurst R.M., Amaratunga C., Lim P., Suon S., Sreng S., Anderson J.M., Mao S., Sam B., et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2014;371:411\u2013423. doi: 10.1056/NEJMoa1314981.", "ArticleIdList": ["10.1056/NEJMoa1314981", "PMC4143591", "25075834"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Paduch R., Kandefer-Szerszen M. Antitumor and Antiviral Activity of Pentacyclic Triterpenes. Mini. Rev. Org. Chem. 2014;11:262\u2013268. doi: 10.2174/1570193X1103140915105240.", "ArticleIdList": ["10.2174/1570193X1103140915105240"]}, {"Citation": "Isah M.B., Ibrahim M.A., Mohammed A., Aliyu A.B., Masola B., Coetzer T.H.T. A systematic review of pentacyclic triterpenes and their derivatives as chemotherapeutic agents against tropical parasitic diseases. Parasitology. 2016;143:1219\u20131231. doi: 10.1017/S0031182016000718.", "ArticleIdList": ["10.1017/S0031182016000718", "27240847"]}, {"Citation": "Bero J., H\u00e9rent M.F., Schmeda-Hirschmann G., Fr\u00e9d\u00e9rich M., Quetin-Leclercq J. In Vivo antimalarial activity of Keetia leucantha twigs extracts and in vitro antiplasmodial effect of their constituents. J. Ethnopharmacol. 2013;149:176\u2013183. doi: 10.1016/j.jep.2013.06.018.", "ArticleIdList": ["10.1016/j.jep.2013.06.018", "23792125"]}, {"Citation": "Beaufay C., H\u00e9rent M.F., Quetin-Leclercq J., Bero J. In Vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts. Malar. J. 2017;16:406. doi: 10.1186/s12936-017-2054-y.", "ArticleIdList": ["10.1186/s12936-017-2054-y", "PMC5635585", "29017554"]}, {"Citation": "Schioppa L., Beaufay D.C., Bonneau D.N., Sanchez D.M., Girardi D.C., Leverrier D.A., Ortiz D.S., Palermo P.J., Poupaert P.J.H., Quetin-Leclercq P.J. Design, Synthesis and Biological Activity of C3 Hemisynthetic Triterpenic Esters as Novel Antitrypanosomal Hits. ChemistryOpen. 2021;10:896. doi: 10.1002/open.202100159.", "ArticleIdList": ["10.1002/open.202100159", "PMC8428374", "34499412"]}, {"Citation": "Rozet E., Hubert C., Ceccato A., Dew\u00e9 W., Ziemons E., Moonen F., Michail K., Wintersteiger R., Streel B., Boulanger B., et al. Using tolerance intervals in pre-study validation of analytical methods to predict in-study results. The fit-for-future-purpose concept. J. Chromatogr. A. 2007;1158:126\u2013137. doi: 10.1016/j.chroma.2007.03.102.", "ArticleIdList": ["10.1016/j.chroma.2007.03.102", "17420025"]}, {"Citation": "Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dew\u00e9 W., Feinberg M., Lallier M., et al. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal\u2014Part II. J. Pharm. Biomed. Anal. 2007;45:70\u201381. doi: 10.1016/j.jpba.2007.06.013.", "ArticleIdList": ["10.1016/j.jpba.2007.06.013", "17646076"]}, {"Citation": "Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dew\u00e9 W., Feinberg M., Lallier M., et al. Harmonization of strategies for the validation of quantitative analytical procedures: A SFSTP proposal\u2014Part I. J. Pharm. Biomed. Anal. 2004;36:579\u2013586. doi: 10.1016/j.jpba.2008.07.018.", "ArticleIdList": ["10.1016/j.jpba.2008.07.018", "15522533"]}, {"Citation": "Rozet E., Ceccato A., Hubert C., Ziemons E., Oprean R., Rudaz S., Boulanger B., Hubert P. Analysis of recent pharmaceutical regulatory documents on analytical method validation. J. Chromatogr. A. 2007;1158:111\u2013125. doi: 10.1016/j.chroma.2007.03.111.", "ArticleIdList": ["10.1016/j.chroma.2007.03.111", "17420026"]}, {"Citation": "Q2 (R1) Validation of Analytical Procedures: Text and Methodology|FDA.  [(accessed on 15 March 2021)]; Available online:  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q2-r1-validation-analytical-procedures-text-and-methodology."}, {"Citation": "Medicines Agency E. 2 ** Committee for Medicinal Products for Human Use (CHMP) Guideline on bioanalytical method validation; 1922.  [(accessed on 20 October 2021)].  Available online:  https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-validation-bionanalytical-methods_en.pdf."}, {"Citation": "European Pharmacopoeia (Ph. Eur.) 10th Edition|EDQM\u2014European Directorate for the Quality of Medicines.  [(accessed on 15 March 2021)].  Available online:  https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition."}, {"Citation": "Lauti\u00e9 E., Rozet E., Hubert P., Quetin Leclercq J. Quantification of rotenone in seeds of different species of yam bean (Pachyrhizus sp.) by a SPE HPLC-UV method. Food Chem. 2012;131:1531\u20131538. doi: 10.1016/j.foodchem.2011.09.125.", "ArticleIdList": ["10.1016/j.foodchem.2011.09.125"]}, {"Citation": "Rozet E., Marini R.D., Ziemons E., Boulanger B., Hubert P. Advances in validation, risk and uncertainty assessment of bioanalytical methods. J. Pharm. Biomed. Anal. 2011;55:848\u2013858. doi: 10.1016/j.jpba.2010.12.018.", "ArticleIdList": ["10.1016/j.jpba.2010.12.018", "21237607"]}, {"Citation": "Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Cohen N., Compagnon P.A., Dew\u00e9 W., Feinberg M., Laurentie M., Mercier N., et al. Harmonization of strategies for the validation of quantitative analytical procedures: A SFSTP proposal. Part IV. Examples of application. J. Pharm. Biomed. Anal. 2008;48:760\u2013771. doi: 10.1016/j.jpba.2008.07.018.", "ArticleIdList": ["10.1016/j.jpba.2008.07.018", "18768284"]}, {"Citation": "Di L., Kerns E.H. Stability Challenges in Drug Discovery. Chem. Biodivers. 2009;6:1875\u20131886. doi: 10.1002/cbdv.200900061.", "ArticleIdList": ["10.1002/cbdv.200900061", "19937822"]}, {"Citation": "Catteau L., Schioppa L., Beaufay C., Girardi C., H\u00e9rent M.F., Fr\u00e9d\u00e9rich M., Quetin-Leclercq J. Antiprotozoal activities of Triterpenic Acids and Ester Derivatives Isolated from the Leaves of Vitellaria paradoxa. Planta Med. 2021;87:860\u2013867. doi: 10.1055/a-1286-1879.", "ArticleIdList": ["10.1055/a-1286-1879", "33285591"]}, {"Citation": "Yu Z., Sun W., Peng W., Yu R., Li G., Jiang T. Pharmacokinetics in vitro and in Vivo of Two Novel Prodrugs of Oleanolic Acid in Rats and Its Hepatoprotective Effects against Liver Injury Induced by CCl4. Mol. Pharm. 2016;13:1699\u20131710. doi: 10.1021/acs.molpharmaceut.6b00129.", "ArticleIdList": ["10.1021/acs.molpharmaceut.6b00129", "27018970"]}, {"Citation": "Chand Gupta A., Bawankule D.U., Verma A.K., Shanker K. Nanoemulsion preconcentrate of a pentacyclic triterpene for improved oral efficacy: Formulation design and in-vivo antimalarial activity. J. Drug Deliv. Sci. Technol. 2020;57:101734. doi: 10.1016/J.JDDST.2020.101734.", "ArticleIdList": ["10.1016/J.JDDST.2020.101734"]}, {"Citation": "Soica C., Trandafirescu C., Danciu C., Muntean D., Dehelean C., Simu G. New improved drug delivery technologies for pentacyclic triterpenes: A review. Protein Pept. Lett. 2014;21:1137\u20131145. doi: 10.2174/0929866521666140807115109.", "ArticleIdList": ["10.2174/0929866521666140807115109", "25106907"]}, {"Citation": "Furtado N.A.J.C., Pirson L., Edelberg H., Miranda L.M., Loira-Pastoriza C., Preat V., Larondelle Y., Andr\u00e9 C.M. Pentacyclic triterpene bioavailability: An overview of in vitro and in vivo studies. Molecules. 2017;22:400. doi: 10.3390/molecules22030400.", "ArticleIdList": ["10.3390/molecules22030400", "PMC6155290", "28273859"]}, {"Citation": "Jeong D.W., Kim Y.H., Kim H.H., Ji H.Y., Yoo S.D., Choi W.R., Lee S.M., Han C.K., Lee H.S. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. Biopharm. Drug Dispos. 2007;28:51\u201357. doi: 10.1002/bdd.530.", "ArticleIdList": ["10.1002/bdd.530", "17163409"]}, {"Citation": "Kartasasmita R., Musfiroh I., Muhtadi A., Ibrahim S. Binding affinity of asiatic acid derivatives design against Inducible Nitric Oxide Synthase and ADMET Prediction ARTICLE INFO ABSTRACT. J. Appl. Pharm. Sci. 2014;4:75\u201380. doi: 10.7324/JAPS.2014.40213.", "ArticleIdList": ["10.7324/JAPS.2014.40213"]}, {"Citation": "Chen D., Huang X., Zhou H., Luo H., Wang P., Chang Y., He X., Ni S., Shen Q., Cao G., et al. Discovery of pentacyclic triterpene 3\u03b2-ester derivatives as a new class of cholesterol ester transfer protein inhibitors. Eur. J. Med. Chem. 2017;139:201\u2013213. doi: 10.1016/j.ejmech.2017.08.012.", "ArticleIdList": ["10.1016/j.ejmech.2017.08.012", "28802120"]}, {"Citation": "Mukkavilli R., Pinjari J., Patel B., Sengottuvelan S., Mondal S., Gadekar A., Verma M., Patel J., Pothuri L., Chandrashekar G., et al. In Vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis. Eur. J. Pharm. Sci. 2014;65:147\u2013155. doi: 10.1016/j.ejps.2014.09.006.", "ArticleIdList": ["10.1016/j.ejps.2014.09.006", "25261338"]}, {"Citation": "Viant M.R., Kurland I.J., Jones M.R., Dunn W.B. How close are we to complete annotation of metabolomes? Curr. Opin. Chem. Biol. 2017;36:64\u201369. doi: 10.1016/j.cbpa.2017.01.001.", "ArticleIdList": ["10.1016/j.cbpa.2017.01.001", "PMC5337156", "28113135"]}, {"Citation": "S\u00e1nchez-Gonz\u00e1lez M., Lozano-Mena G., Parra A., Juan M.E., Planas J.M. Identification in rat plasma and urine by linear trap quadrupole-orbitrap mass spectrometry of the metabolites of maslinic acid, a triterpene from olives. J. Agric. Food Chem. 2015;63:1126\u20131132. doi: 10.1021/jf505379g.", "ArticleIdList": ["10.1021/jf505379g", "25575098"]}, {"Citation": "Xia B., Bai L., Li X., Xiong J., Xu P., Xue M. Structural Analysis of Metabolites of Asiatic Acid and Its Analogue Madecassic Acid in Zebrafish Using LC/IT-MSn. Molecules. 2015;20:3001\u20133019. doi: 10.3390/molecules20023001.", "ArticleIdList": ["10.3390/molecules20023001", "PMC6272356", "25685908"]}, {"Citation": "Moneriz C., Mestres J., Bautista J.M., Diez A., Puyet A. Multi-targeted activity of maslinic acid as an antimalarial natural compound. FEBS J. 2011;278:2951\u20132961. doi: 10.1111/j.1742-4658.2011.08220.x.", "ArticleIdList": ["10.1111/j.1742-4658.2011.08220.x", "21689375"]}, {"Citation": "Mulli\u00e9 C., Jonet A., Dassonville-Klimpt A., Gosmann G., Sonnet P. Inhibitory effect of ursolic acid derivatives on hydrogen peroxide- and glutathione-mediated degradation of hemin: A possible additional mechanism of action for antimalarial activity. Exp. Parasitol. 2010;125:202\u2013207. doi: 10.1016/j.exppara.2010.01.016.", "ArticleIdList": ["10.1016/j.exppara.2010.01.016", "20109452"]}, {"Citation": "Maya J.D., Cassels B.K., Iturriaga-V\u00e1squez P., Ferreira J., Fa\u00fandez M., Galanti N., Ferreira A., Morello A. Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp. Biochem. Physiol. Part A Mol. Integr. Physiol. 2007;146:601\u2013620. doi: 10.1016/j.cbpa.2006.03.004.", "ArticleIdList": ["10.1016/j.cbpa.2006.03.004", "16626984"]}, {"Citation": "Agency E.M. Guideline on Bioanalytical Method Validation. 2011.  [(accessed on 20 October 2021)].  Available online:  https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf."}, {"Citation": "Kessner D., Chambers M., Burke R., Agus D., Mallick P. ProteoWizard: Open source software for rapid proteomics tools development. Bioinformatics. 2008;24:2534\u20132536. doi: 10.1093/bioinformatics/btn323.", "ArticleIdList": ["10.1093/bioinformatics/btn323", "PMC2732273", "18606607"]}, {"Citation": "Smith C.A., Want E.J., O\u2019Maille G., Abagyan R., Siuzdak G. XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 2006;78:779\u2013787. doi: 10.1021/ac051437y.", "ArticleIdList": ["10.1021/ac051437y", "16448051"]}, {"Citation": "Giacomoni F., Le Corguille G., Monsoor M., Landi M., Pericard P., P\u00e9t\u00e9ra M., Duperier C., Tremblay-Franco M., Martin J.-F., Jacob D. Workflow4Metabolomics: A collaborative research infrastructure for computational metabolomics. Bioinformatics. 2015;31:1493\u20131495. doi: 10.1093/bioinformatics/btu813.", "ArticleIdList": ["10.1093/bioinformatics/btu813", "PMC4410648", "25527831"]}, {"Citation": "Kuhl C., Tautenhahn R., B\u00f6ttcher C., Larson T.R., Neumann S. CAMERA: An integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets. Anal. Chem. 2012;84:283\u2013289. doi: 10.1021/ac202450g.", "ArticleIdList": ["10.1021/ac202450g", "PMC3658281", "22111785"]}, {"Citation": "Rev 1 * EU Individual Case Safety Report (ICSR) 1 Implementation Guide Start of Public Consultation of First Version Individual Case Safety Reports (ICSRs) in Pharmacovigilance\u2014Part 2: Human Pharmaceutical Reporting Requirements for ICSR (ISO 27953-2:2011) and the ICH E2B(R3) Implementation Guide. 2017.  [(accessed on 20 October 2021)].  Available online:  https://ich.org/page/e2br3-individual-case-safety-report-icsr-specification-and-related-files."}, {"Citation": "Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Cohen N., Compagnon P.A., Dew\u00e9 W., Feinberg M., Laurentie M., Mercier N., et al. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal-Part III. J. Pharm. Biomed. Anal. 2007;45:82\u201396. doi: 10.1016/j.jpba.2007.06.032.", "ArticleIdList": ["10.1016/j.jpba.2007.06.032", "17716847"]}, {"Citation": "Rafamantanana M.H., Rozet E., Raoelison G.E., Cheuk K., Ratsimamanga S.U., Hubert P., Quetin-Leclercq J. An improved HPLC-UV method for the simultaneous quantification of triterpenic glycosides and aglycones in leaves of Centella asiatica (L.) Urb (APIACEAE) J. Chromatogr. B. 2009;877:2396\u20132402. doi: 10.1016/j.jchromb.2009.03.018.", "ArticleIdList": ["10.1016/j.jchromb.2009.03.018", "19349219"]}, {"Citation": "Corning\u00ae GentestTM Mouse (B6C3F1) Pooled Liver Microsomes, Male, 0.5 mL|B6C3F1, Male|Microsome Type|Life Sciences EU Other Consumer Site|Corning.  [(accessed on 4 March 2021)].  Available online:  https://ecatalog.corning.com/life-sciences/b2c/EUOther/en/ADME-Tox-Research/Tissue-Fractions/Animal-Liver-Fractions/Animal-Liver-Tissue-Fraction-Products---Corning\u00ae-GentestTM-Animal-Pooled-Liver-Microsomes-Mouse-Liver-Microsomes/p/452220."}, {"Citation": "Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265\u2013275. doi: 10.1016/S0021-9258(19)52451-6.", "ArticleIdList": ["10.1016/S0021-9258(19)52451-6", "14907713"]}, {"Citation": "Mohutsky M.A., Chien J.Y., Ring B.J., Wrighton S.A. Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations. Pharm. Res. 2006;23:654\u2013662. doi: 10.1007/s11095-006-9663-4.", "ArticleIdList": ["10.1007/s11095-006-9663-4", "16550474"]}, {"Citation": "Greenblatt D.J. Elimination half-life of drugs: Value and limitations. Annu. Rev. Med. 1985;36:421\u2013427. doi: 10.1146/annurev.me.36.020185.002225.", "ArticleIdList": ["10.1146/annurev.me.36.020185.002225", "3994325"]}, {"Citation": "Bohnert T., Gan L.L. Handbook of Metabolic Pathways of Xenobiotics. John Wiley & Sons, Ltd.; Chichester, UK: 2013. In Vitro Experimental Models for Studying Drug Biotransformation; pp. 1\u201361."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "26"}, {"Year": "2021", "Month": "11", "Day": "20"}, {"Year": "2021", "Month": "11", "Day": "22"}, {"Year": "2021", "Month": "12", "Day": "10", "Hour": "1", "Minute": "8"}, {"Year": "2021", "Month": "12", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["34885738", "PMC8659078", "10.3390/molecules26237154", "molecules26237154"]}}], "PubmedBookArticle": []}